secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2023-09-27T23:59:59+00:00
Accession:  0001193125-23-243881
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno terminates at-the-market offering agreement with Cantor Fitzgerald; $7.67M sold out of $8.88M authorized
--------------------------------------------------------------------------------

- Terminated Controlled Equity Offering Sales Agreement with Cantor Fitzgerald effective September 26, 2023.
- Under the ATM prospectus, $7.67M of common stock sold out of $8.88M authorized capacity.
- No further sales of common stock will be made under the ATM program.
- Cantor waived the termination notice period, making termination immediate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523243881/0001193125-23-243881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523243881/d555949d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-243881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer